Praxis Precision Medicines Inc (PRAX) returns
Praxis Precision Medicines returns over 5 years
$1,000 invested in Praxis Precision Medicines five years ago was worth $916.44 at the close on October 30, 2026, with dividends reinvested: an average return of -1.7% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -1.8% | — | $981.80 | -0.9% |
| 3 months | -7.1% | — | $929.10 | +2.1% |
| Year to date | -3.0% | — | $970.11 | +11.7% |
| 1 year | +42.3% | — | $1,423 | +12.4% |
| 3 years | +1,778% | +165.8% | $18,780 | +88.5% |
| 5 years | -8.4% | -1.7% | $916.44 | +76.0% |
Praxis Precision Medicines return by calendar year
| Year | PRAX | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -3.0% | +11.7% | -14.7% |
| 2025 | +283.0% | +17.7% | +265.3% |
| 2024 | +245.4% | +24.9% | +220.5% |
| 2023 | -37.6% | +26.2% | -63.8% |
| 2022 | -87.9% | -18.2% | -69.7% |
| 2021 | -64.2% | +28.7% | -92.9% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Praxis Precision Medicines Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.